Skinvisible, Inc. (SKVI)

Market Cap	2.03M +163.6%
Revenue (ttm)	20.00K
Net Income	-490.91K
EPS	-0.09
Shares Out	5.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50
Average Volume	3,161
Open	0.2101
Previous Close	0.3763
Day's Range	0.2101 - 0.3763
52-Week Range	0.0811 - 0.9000
Beta	1.60
RSI	49.91
Earnings Date	Feb 13, 2026

About Skinvisible

Skinvisible, Inc. focuses on the development, manufacture, and sale of topical, transdermal, and mucosal polymer-based delivery system technologies and formulations for use in pharmaceutical, over-the-counter, personal skincare, and cosmetic arenas. Its non-dermatological formulations offer solutions for women’s health, pain management, and other markets. The company’s flagship product includes Invisicare, a patented polymer delivery system technology that enhances the delivery of active ingredients for topically applied skin care products. It ...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 1998
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: SKVI

Financial Performance

In 2024, Skinvisible's revenue was $20,000, a change of 0.00% compared to the previous year's $20,000. Losses were -$565,654, -76.26% less than in 2023.